BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9808075)

  • 1. Increased serum concentrations of soluble tumor necrosis factor receptors p55 and p75 in early onset neonatal sepsis.
    Doellner H; Arntzen KJ; Haereid PE; Aag S; Brubakk AM; Austgulen R
    Early Hum Dev; 1998 Oct; 52(3):251-61. PubMed ID: 9808075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules.
    Døllner H; Vatten L; Austgulen R
    J Clin Epidemiol; 2001 Dec; 54(12):1251-7. PubMed ID: 11750194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis.
    Døllner H; Vatten L; Linnebo I; Zanussi GF; Laerdal A ; Austgulen R
    Biol Neonate; 2001 Jul; 80(1):41-7. PubMed ID: 11474148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations.
    Pilz G; Fraunberger P; Appel R; Kreuzer E; Werdan K; Walli A; Seidel D
    Crit Care Med; 1996 Apr; 24(4):596-600. PubMed ID: 8612409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
    Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.
    Davas EM; Tsirogianni A; Kappou I; Karamitsos D; Economidou I; Dantis PC
    Clin Rheumatol; 1999; 18(1):17-22. PubMed ID: 10088943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome.
    Vinante F; Rigo A; Tecchio C; Morosato L; Nadali G; Ricetti MM; Krampera M; Zanolin E; Locatelli F; Gallati H; Chilosi M; Pizzolo G
    Br J Haematol; 1998 Sep; 102(4):1025-34. PubMed ID: 9734654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis.
    Gattorno M; Picco P; Buoncompagni A; Stalla F; Facchetti P; Sormani MP; Pistoia V
    Ann Rheum Dis; 1996 Apr; 55(4):243-7. PubMed ID: 8733441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4, interleukin-10, and soluble tumor necrosis factor receptors in cord blood.
    Hata T; Kawamura T; Fujiwaki R; Aoki S; Hata K; Inada K
    Gynecol Obstet Invest; 1997; 43(3):155-7. PubMed ID: 9127126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
    Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
    Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
    J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-mediated neutrophil apoptosis and associated A1 protein expression during systemic inflammation are regulated independently of both tumor necrosis factor receptors.
    Kotani J; Avallone NJ; Lin E; Goshima M; Gandhi K; Lowry SF; Calvano SE
    Shock; 2003 Mar; 19(3):201-7. PubMed ID: 12630518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble tumor necrosis factor receptors in sera from patients with insulin-dependent diabetes mellitus: relations to duration and complications of disease.
    Kulseng B; Vatten L; Espevik T
    Acta Diabetol; 1999 Jun; 36(1-2):99-105. PubMed ID: 10436260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection.
    Messer J; Eyer D; Donato L; Gallati H; Matis J; Simeoni U
    J Pediatr; 1996 Oct; 129(4):574-80. PubMed ID: 8859265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of sTNFR p75 and TNF alpha in dengue-infected patients.
    Hober D; Delannoy AS; Benyoucef S; De Groote D; Wattré P
    Microbiol Immunol; 1996; 40(8):569-73. PubMed ID: 8887351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
    Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
    Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
    Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
    J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.
    Frissen PH; Weverling GJ; Endert E; Jansen J; Sauerwein HP; Lange JM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):482-8. PubMed ID: 8757425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.